Drawing for ATTSITE

USPTO serial 86598934

ATTSITE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
VIGIL, JACOB EUGENE
Law office
TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ATTSITE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David L. May

DAVID L. MAY Nixon Peabody Llp401 9th St NW Ste 900Washington, DC 20004-2145UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Research reagents for pharmaceutical discovery or disease research, drug discovery or drug development; Chemicals for use in biochemical and chemical industry; chemicals for use in agriculture, food production, energy conversion, and production of environmentally-friendly chemical solutions; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; Chemical modifiers of gene expression in plants, mammals, fungi and microbes for industrial and agricultural applications; Chemicals and chemical reagents, namely, for production of cells and transgenic animals, transgenic plants and transgenic fungi, and cells of animals, plants or fungi for use in medical, pharmaceutical and veterinary laboratory researchACTIVE—
005Chemical modifiers of gene expression in plants, mammals, fungi and bacteria for medical and veterinary applications; Pharmaceutical and veterinary preparations which regulate the cellular functions of fungi, plants, bacteria and mammals and transgenic fungi, plants, bacteria and mammals; transgenic fungi and bacteria for medical and veterinary purposesACTIVE—
040Custom manufacturing and custom synthesis of genetically engineered DNA, biological organisms, cells, viruses, and special purpose cells to the specifications of others for scientific, research, medical and laboratory useACTIVE—
042Development of new technology for others in the fields of medicine, genetics, therapeutics, biotechnology, agriculture, energy, fuels, biofuels, biochemistry, the chemical industry, and the environment; Development of products being genetic approaches effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of biotechnological processes to regulate, modulate, and characterize cell function or disease states; Research and development services for others in the fields of biotechnology and genetics, namely, genetically engineering DNA, biological organisms, cells, viruses, and special purpose cells for scientific, research, medical and laboratory use; Scientific research and product development services for others in the pharmaceutical, chemical, biochemical, biotechnology, biosensors, bioelectronics, medical, animal therapeutics, energy, fuels, biofuels, and agriculture fields; Gene therapy services for others for product development and scientific research purposes, namely, genetically engineering DNA, biological organisms, cells, viruses, and special purpose cells for scientific, research, medical and laboratory useACTIVE—
044Medical services; Medical services, namely, gene therapy servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jan 7, 2016MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 7, 2016ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 11, 2015GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 11, 2015GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 11, 2015CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jun 5, 2015DOCKASSIGNED TO EXAMINER—
Apr 24, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED—
Apr 23, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 18, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance